Bone density and bone turnover marker monitoring after discontinuation of alendronate therapy: an evidence-based decision to do less
- PMID: 24798510
- DOI: 10.1001/jamainternmed.2014.162
Bone density and bone turnover marker monitoring after discontinuation of alendronate therapy: an evidence-based decision to do less
Comment on
-
Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.JAMA Intern Med. 2014 Jul;174(7):1126-34. doi: 10.1001/jamainternmed.2014.1232. JAMA Intern Med. 2014. PMID: 24798675 Free PMC article. Clinical Trial.
Similar articles
-
Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study.JAMA Intern Med. 2014 Jul;174(7):1126-34. doi: 10.1001/jamainternmed.2014.1232. JAMA Intern Med. 2014. PMID: 24798675 Free PMC article. Clinical Trial.
-
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.
-
Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.J Clin Oncol. 2008 Sep 20;26(27):4426-34. doi: 10.1200/JCO.2007.15.1233. J Clin Oncol. 2008. PMID: 18802155 Free PMC article. Clinical Trial.
-
[FACT study].Nihon Rinsho. 2007 Nov 28;65 Suppl 9:280-5. Nihon Rinsho. 2007. PMID: 18161120 Review. Japanese. No abstract available.
-
[Current osteoporosis treatment: reasons for adding vitamin D to alendronate].Reumatizam. 2006;53(2):63-5. Reumatizam. 2006. PMID: 17580557 Review. Croatian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical